All > Waldenstrom Macroglobulinemia > Myeloma

PROLONGED FASTING INTERVENTION for Cancer Prevention

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Cancer Prevention+5 MoreProlonged Fasting Intervention - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether a prolonged nightly fasting intervention can prevent overweight and obese individuals with blood cancer from developing the disease.

Eligible Conditions
  • Cancer Prevention
  • Monoclonal Gammopathy of Unknown Significance
  • Weight Loss
  • Fasting
  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
BWLT
1
Radiation Therapy
1
CART123 cells; cyclophosphamide; fludarabine

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: Baseline to 4-months

Baseline to 4-months
(M-)protein concentrations/light chains change by mass spectrometry
Bone Marrow
Mass Spectrometry
baseline to 4-months
Changes in body composition
Body Weight Changes

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
BWLT
1
Radiation Therapy
1
CART123 cells; cyclophosphamide; fludarabine

Trial Design

2 Treatment Groups

EDUCATION CONTROL
1 of 2
PROLONGED FASTING INTERVENTION
1 of 2

Active Control

Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: PROLONGED FASTING INTERVENTION · No Placebo Group · N/A

PROLONGED FASTING INTERVENTION
Behavioral
Experimental Group · 1 Intervention: Prolonged Fasting Intervention · Intervention Types: Behavioral
EDUCATION CONTROL
Behavioral
ActiveComparator Group · 1 Intervention: EDUCATION CONTROL · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 4-months

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,016 Previous Clinical Trials
393,776 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,071 Previous Clinical Trials
41,128,815 Total Patients Enrolled
3 Trials studying Cancer Prevention
1,233 Patients Enrolled for Cancer Prevention
Catherine Marinac, Ph.DPrincipal InvestigatorDana-Farber Cancer Institute

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are at least 18 years old.
You are currently fasting for <14 hours per night, as assessed using 24-hour food recalls.
You own a cell phone and are comfortable sending and receiving text messages.
You are able to understand the nature and purpose of the study and are willing to sign a written informed consent document.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top